ASHLEY WORTHINGTON: Open Payments
NPI 1457825481 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,814 in 121 payments from 16 companies in 2025. Trend: 2023 $3,835 · 2024 $2,352 · 2025 $2,814
Food & beverage: $2,801Education: $13
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 22 | $602 |
| ABBVIE INC. | 24 | $424 |
| Arcutis Biotherapeutics, Inc. | 4 | $328 |
| Novartis Pharmaceuticals Corporation | 8 | $184 |
| Incyte Corporation | 6 | $178 |
| Regeneron Healthcare Solutions, Inc. | 2 | $170 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $168 |
| PFIZER INC. | 14 | $160 |
| UCB, Inc. | 12 | $156 |
| Janssen Biotech, Inc. | 8 | $148 |
Products named: NEMLUVIO, Zoryve, SKYRIZI, OPZELURA, LIBTAYO, TREMFYA, CIBINQO, Bimzelx.
Industry payments across IN — which companies pay providers there.
